IMAC Holdings Inc (BACK)

A. Company Overview

IMAC Holdings Inc. is a healthcare provider that specializes in offering value-based, conservative medical care tailored for movement-restricting diseases and conditions. The company operates through its IMAC Regeneration Centers and BackSpace clinics, focusing on innovative medical advancements that combine traditional medical care with contemporary treatments. Historically, IMAC Holdings aimed to improve patient conditions while reducing healthcare costs relative to conventional treatment options available for similar ailments.

As of December 31, 2023, the company has closed or divested its outpatient clinics that provided regenerative, orthopedic, and minimally invasive medical procedures. The primary focus in patient care has been on providing customized treatment plans that integrate various medical protocols. These include traditional minimally invasive procedures, regenerative medicine, physical therapies, and chiropractic care. The services provided do not involve prescribing opioids, as IMAC Holdings seeks to offer alternatives to conventional surgery and joint replacement.

B. Historical Background

The history of IMAC Holdings traces back to August 2000 when Dr. Matthew Wallis, a licensed chiropractor, opened the first IMAC Regeneration Center in Paducah, Kentucky, which served as the flagship location. The company expanded significantly over the years, and in 2015, Dr. Wallis, along with Dr. Jason Brame, introduced Jeffrey S. Ervin as the CEO to execute a growth strategy. IMAC Holdings LLC was formed to manage and operate clinics transitioning from the Kentucky area. This structure paved the way for a corporate conversion in June 2018, when the company transitioned to IMAC Holdings, Inc., to consolidate control over existing clinics.

In February 2019, IMAC Holdings completed an initial public offering and began trading on the Nasdaq Capital Market, representing a significant milestone in its financial strategy.

C. Services Offered

IMAC Holdings specializes in a broad spectrum of treatment methodologies aimed at enhancing patient outcomes through innovative therapies. Key service segments include:

Medical Treatments

Emphasizing minimally invasive procedures, IMAC’s medical team focuses on treating underlying conditions rather than relying on prescriptions or surgical interventions. These procedures are designed to alleviate movement challenges associated with orthopedic conditions.

Regenerative Medicine

Regenerative treatments at IMAC utilize undifferentiated cellular tissue sourced from patients themselves, allowing for procedures that aim to heal damaged tissues. This includes platelet therapies that are predominant in their offerings, supported by a growing body of independent research advocating for the efficacy of such techniques in treating pain associated with conditions like osteoarthritis.

Physical Medicine

Customized physical medicine treatment plans are developed to help patients regain functionality and quality of life, integrating biomechanical loading and tissue mobilization.

Physical Therapy

Licensed physical rehabilitation therapists support recovery initiatives aimed at restoring functional capability within joints and soft tissues.

Chiropractic Manipulation

Chiropractic services aim to enhance range of motion, decrease nerve irritability, and improve overall function, chiefly for spine-related conditions.

D. Recent Developments

The company’s operational strategy has seen substantial transformations, especially in 2023, by closing underperforming clinics and divesting various locations to bolster financial sustainability. These strategic closures included significant sales of assets from various clinics across multiple states.

In May 2023, a merger agreement with Theralink Technologies was established, whereby IMAC Holdings plans to assimilate Theralink into its operational framework. This merger presents an opportunity for IMAC to expand its service offerings and amplify its market presence.

E. Market Position

IMAC Holdings positions itself as a competitive provider within the healthcare landscape, largely due to the increasing consumer demand for non-invasive, organic healthcare solutions. As an alternative to traditional orthopedic surgeries, IMAC asserts that its regenerative rehabilitation treatments are offered at significantly lower price points compared to surgical interventions, which can incur exorbitant costs and longer recovery times.

The establishment of strict pre-approval processes for surgeries, particularly regarding opioid prescriptions tied to postoperative care, has further solidified the relevance of IMAC’s non-opioid treatment methodologies. The company has positioned itself favorably against traditional orthopedic surgeons, pain management clinics, and hospital systems by advocating for its patient-centric approach that prioritizes safety and effectiveness without opioids.

F. Leadership and Management

IMAC Holdings is overseen by a suite of professionals with extensive experience in healthcare services. The leadership team, which includes co-founders Dr. Wallis and Dr. Brame, and CEO Jeffrey S. Ervin, possesses a cumulative wealth of knowledge that exceeds a century. The executives have been instrumental in creating operational efficiencies and steering the company towards its growth trajectory.

G. Intellectual Property and Regulatory Compliance

IMAC Holdings is vigilant in protecting its proprietary information through trademarks, confidentiality measures, and compliance with state and federal healthcare regulations. Obligations relating to healthcare privacy, fraud prevention, and operational efficiency are enforced through adherence to laws such as HIPAA and regulations governing healthcare service providers. The company continually evaluates regulatory standards to maintain compliance across its operations, mitigating potential risks associated with violations.